Area of research
Oncology · Immunology
Research interest
Research interests include Immunotherapy and Immune Responses, vaccines and immunoinformatics approaches, Viral-associated cancers and disorders, and CAR-T cell therapy research.
Tumor cell-based liquid biopsy using high-throughput microfluidic enrichment of entire leukapheresis product
Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy
Immune responses in checkpoint myocarditis across heart, blood and tumour
Single-cell transcriptomic analyses reveal distinct immune cell contributions to epithelial barrier dysfunction in checkpoint inhibitor colitis
Cancer cells restrict immunogenicity of retrotransposon expression via distinct mechanisms
Disruption of cellular plasticity by repeat RNAs in human pancreatic cancer
Ultrasensitive Detection of Circulating LINE-1 ORF1p as a Specific Multicancer Biomarker
TGF-β in the microenvironment induces a physiologically occurring immune-suppressive senescent state
Reverse Transcriptase Inhibition Disrupts Repeat Element Life Cycle in Colorectal Cancer
Differential Kinase Activity Across Prostate Tumor Compartments Defines Sensitivity to Target Inhibition
Spatially organized multicellular immune hubs in human colorectal cancer
NR4A1 regulates expression of immediate early genes, suppressing replication stress in cancer
The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis
HIF1A signaling selectively supports proliferation of breast cancer in the brain
Microfluidic concentration and separation of circulating tumor cell clusters from large blood volumes
Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer
Epithelial to mesenchymal plasticity and differential response to therapies in pancreatic ductal adenocarcinoma
SETD1A protects from senescence through regulation of the mitotic gene expression program
Molecular signatures of circulating melanoma cells for monitoring early response to immune checkpoint therapy